Cargando…
Changes in the gut microbiome and fermentation products concurrent with enhanced longevity in acarbose-treated mice
BACKGROUND: Treatment with the α-glucosidase inhibitor acarbose increases median lifespan by approximately 20% in male mice and 5% in females. This longevity extension differs from dietary restriction based on a number of features, including the relatively small effects on weight and the sex-specifi...
Autores principales: | Smith, Byron J, Miller, Richard A, Ericsson, Aaron C, Harrison, David C, Strong, Randy, Schmidt, Thomas M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567620/ https://www.ncbi.nlm.nih.gov/pubmed/31195972 http://dx.doi.org/10.1186/s12866-019-1494-7 |
Ejemplares similares
-
Muribaculaceae Genomes Assembled from Metagenomes Suggest Genetic Drivers of Differential Response to Acarbose Treatment in Mice
por: Smith, Byron J., et al.
Publicado: (2021) -
Acarbose improves health and lifespan in aging HET3 mice
por: Harrison, David E., et al.
Publicado: (2019) -
Enhanced Production of Acarbose and Concurrently Reduced Formation of Impurity C by Addition of Validamine in Fermentation of Actinoplanes utahensis ZJB-08196
por: Xue, Ya-Ping, et al.
Publicado: (2013) -
The Glucoamylase Inhibitor Acarbose Has a Diet-Dependent and Reversible Effect on the Murine Gut Microbiome
por: Baxter, Nielson T., et al.
Publicado: (2019) -
The gut microbiome of laboratory mice: considerations and best practices for translational research
por: Ericsson, Aaron C., et al.
Publicado: (2021)